TGFB1 and pulmonary fibrosis: Taken together, it is considered that the elimination of ROS by the antioxidant action of the Si-based agent led to the break-down of a vicious cycle of increased oxidative stress and abnormal activity of TGF-β, and hence alleviated lung fibrosis.